Update in postmenopausal osteoporosis management


Why we should use tools to evaluate osteoporosis risk? Olivier Bruyère (ULG)

Role of biochemical assessments in the management of osteoporosis. Etienne Cavalier (ULiège) Slides Belgian Menopause society avril 2022

Bisphosphonates vs. denosumab: Advantages and risks. Charlotte Verroken (UGent) Bisphosphonates vs. denosumab

MHT and SERMS for osteoporosis: do they still have a place? Serge Rozenberg (ULB-VUB) BMS osteoporosis 30.4.22 (1)

Satellite symposium UCB Romososumab: Results of trials, positioning and indications Evelien Gielen

Next meeting

Our next BMS meeting Saturday June 1st: Topic : “ Menopause Hormones, no hormones and anti-hormones?”

Latest news

The effect of music on menopausal symptoms, sleep quality,and depression: a RCT Ugurlu M, et al ( Rev Assoc Med Bras (1992). 2024 Jan 22;70(2):e20230829. doi: 10.1590/1806-9282.20230829.)